Cite
HARVARD Citation
Pegourie, B. et al. (n.d.). Apixaban for the prevention of thromboembolism in immunomodulatory‐treated myeloma patients: Myelaxat, a phase 2 pilot study. American journal of hematology. 94 (6), pp. 635-640. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pegourie, B. et al. (n.d.). Apixaban for the prevention of thromboembolism in immunomodulatory‐treated myeloma patients: Myelaxat, a phase 2 pilot study. American journal of hematology. 94 (6), pp. 635-640. [Online].